1. Anon., 2001. Medicines Control Agency Meeting, London UK, December 2001.
2. Structure–activity relationship on human serum paraoxonase (PON1) using substrate analogies and inhibitors;Bargota;Bioorganic & Medicinal Chemistry Letters,2003
3. Barguil, Y., 2001. Kava and gamma-glutamyltransferase increase: hepatic enzymatic induction or liver function alteration. Electronic letter. Available from http://www.bmj.com 21March, in response to Escher et al., 2001.
4. Clough, A., 2002. Epidemiological studies on kava use and side effects in Arnhem Land Aborigines, Menzies University. Personal Communication.
5. Dayton, K., 2003. UH scientists may have solved kava mystery. Available from http://www.the honoluluadvertiser.com/article/2003/Apr/07/In/In03a.html.